Accepted abstracts will be published in a supplement issue of the American Journal of Cardiology (AJC).
Late-Breaking Clinical Trial
•
The clinical research of Late-Breaking Clinical Trial should be related with the randomized clinical trial and the main topic of ANGIOPLASTY SUMMIT-TCTAP.
•
Selected Late-Breaking Clinical Trials will be presented at the Main Arena during the meeting.
Oral Abstract Competition Session
•
The Best abstracts will be presented orally at the Main Arena and the abstract presenter will be awarded the prize.
•
The Moderated Competition Session will be presented 5 abstracts each and the winner selected by moderators and panelists will be awarded the prize.
•
The selected oral abstract will be scheduled as 10-minute presentations and 5-minute discussions in English.
E-poster Abstracts
•
The selected abstracts will be also displayed as e-posters
abstract at the venue during the meeting.
•
E-poster abstracts will be viewable at the Cyber station and also
available to communicate with authors or send them to collegues at
any time.
<Submission Guideline>
* Please send an e-mail with E-poster abstract format as below.
a. E-poster abstract format: PowerPoint up to 15 slides, File name: AS-number
b. Maximum capacity : 1 MB
c. Submission deadline: March 9 (Fri.), 2012
* Please make sure that the
name of co-author on the E-poster is the same as that of the
accepted abstract.
Revision
•
Abstract revision can be made until January 31, 2012 and any change will not be accepted after the submission deadline.
All accepted abstract presenters will be waived from the registration fee
No show policy
•
Please notify the Organizing Committee via e-mail at abstract@summitmd.com if your presentation will not be made in advance. If a scheduled presenter fails to appear in person or to send a replacement, and does not cancel Oral abstract presentation before the meeting, that presenter will be barred from having an abstract accepted in the ANGIOPLASTY SUMMIT-TCTAP for one year.
For any assistance, please contact secretariat Ms. Yoonyoung Cho Tel: 82-2-3010-4707 | Fax: 82-2-475-6898 E-mail: abstract@summitmd.com
Late-Breaking Clinical Trial
